U.S., Jan. 31 -- ClinicalTrials.gov registry received information related to the study (NCT07379645) titled 'A Clinical Trial of PepZinGI(R) for Acute Heartburn Relief and Sleep Outcomes' on Jan. 09.
Brief Summary: This decentralized, randomized, double-blind, placebo-controlled, two-period crossover study will evaluate whether PepZinGI(R) (zinc-L-carnosine) reduces food-triggered heartburn compared with placebo. Participants (N=50) complete two 1-week treatment periods (PepZinGI(R) and placebo) separated by a 2-week washout, for a total of 29 days. Primary outcomes are heartburn severity and frequency measured by the NutriScience Heartburn Questionnaire; secondary outcomes include PROMIS GI Reflux-13a, time to relief, rescue medication us...